Cargando…

Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration

Choroidal neovascularization (CNV) is the key pathological event of wet age‐related macular degeneration (wAMD) leading to irreversible vision loss. Currently, anti‐angiogenic therapy with anti‐vascular endothelial growth factor (VEGF) agents has become the standard treatment for wAMD, while it is s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Shuting, Cui, Kaixuan, Long, Kaiqi, Li, Jia, Fan, Ni, Lam, Wai‐Ching, Liang, Xiaoling, Wang, Weiping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10625062/ https://www.ncbi.nlm.nih.gov/pubmed/37705491 http://dx.doi.org/10.1002/advs.202301985

Ejemplares similares

Red Light‐Triggered Anti‐Angiogenic and Photodynamic Combination Therapy of Age‐Related Macular Degeneration (Adv. Sci. 31/2023)
por: Xu, Shuting, et al.
Publicado: (2023)

Green Light‐Triggered Intraocular Drug Release for Intravenous Chemotherapy of Retinoblastoma
por: Long, Kaiqi, et al.
Publicado: (2021)

One-photon red light-triggered disassembly of small-molecule nanoparticles for drug delivery
por: Long, Kaiqi, et al.
Publicado: (2021)

Efficacy of ranibizumab combined with photodynamic therapy on wet age-related macular degeneration
por: Chen, Ling, et al.
Publicado: (2020)

Extreme retinal remodeling triggered by light damage: implications for age related macular degeneration
por: Marc, Robert E., et al.
Publicado: (2008)

TCCR/WSX-1 is a novel angiogenic factor in age-related macular degeneration
por: Sung, Ho Jin, et al.
Publicado: (2012)

Synthetic anti-angiogenic genomic therapeutics for treatment of neovascular age-related macular degeneration
por: Wang, Jing, et al.
Publicado: (2021)

Novel Programmed Cell Death as Therapeutic Targets in Age-Related Macular Degeneration?
por: Yang, Ming, et al.
Publicado: (2020)

Combined treatment of exudative age related macular degeneration with photodynamic therapy and intravitreal triamcinolone
por: Ruiz-Moreno, José Mª, et al.
Publicado: (2008)

The effect of ranibizumab versus photodynamic therapy on DNA damage in patients with exudative macular degeneration
por: Mozaffarieh, M, et al.
Publicado: (2009)

Preclinical Efficacy of Pro- and Anti-Angiogenic Peptide Hydrogels to Treat Age-Related Macular Degeneration
por: Acevedo-Jake, Amanda, et al.
Publicado: (2021)

Neovascular age-related macular degeneration: intraocular inflammatory cytokines in the poor responder to ranibizumab treatment
por: Pongsachareonnont, Pear, et al.
Publicado: (2018)

Red Upconverter Nanocrystals Functionalized with Verteporfin for Photodynamic Therapy Triggered by Upconversion
por: Miletto, Ivana, et al.
Publicado: (2022)

7-Ketocholesterol Increases Retinal Microglial Migration, Activation, and Angiogenicity: A Potential Pathogenic Mechanism Underlying Age-related Macular Degeneration
por: Indaram, Maanasa, et al.
Publicado: (2015)

Combined Treatment of Photodynamic Therapy and Bevacizumab for Choroidal Neovascularization Secondary to Age-Related Macular Degeneration
por: Kim, Hyun Woong, et al.
Publicado: (2011)

Changes in visual function and thickness of macula after photodynamic therapy for age-related macular degeneration
por: Okada, Kyoko, et al.
Publicado: (2009)

Effect of anti-VEGF drugs combined with photodynamic therapy in the treatment of age-related macular degeneration
por: Dong, Yi, et al.
Publicado: (2016)

Single-session photodynamic therapy combined with intravitreal bevacizumab and triamcinolone for neovascular age-related macular degeneration
por: Ahmadieh, Hamid, et al.
Publicado: (2007)

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration
por: Nakamura, Tomoko, et al.
Publicado: (2012)

Five-year results of photodynamic therapy with verteporfin for Japanese patients with neovascular age-related macular degeneration
por: Tsuchihashi, Takashi, et al.
Publicado: (2013)

Prognostic phenotypic and genotypic factors associated with photodynamic therapy response in patients with age-related macular degeneration
por: Tsuchihashi, Takashi, et al.
Publicado: (2014)

Association of gene polymorphism with serum levels of inflammatory and angiogenic factors in Pakistani patients with age-related macular degeneration
por: Ambreen, Fareeha, et al.
Publicado: (2015)

Prevention of age-related macular degeneration
por: Wong, Ian Yat Hin, et al.
Publicado: (2010)

Foveal atrophy and macular hole formation following intravitreal ranibizumab with/without photodynamic therapy for choroidal neovascularization secondary to age-related macular degeneration
por: Rishi, Pukhraj, et al.
Publicado: (2011)

Combined intravitreal bevacizumab and photodynamic therapy with vertiporfin for management of choroidal neovascularization secondary to age-related macular degeneration
por: Kabeel, Mamdouh M, et al.
Publicado: (2008)

Combined photodynamic therapy and intravitreal ranibizumab as treatment for extrafoveal choroidal neovascularization associated with age-related macular degeneration
por: Chhablani, Jay Kumar
Publicado: (2010)

Long-term outcomes of combination photodynamic therapy with ranibizumab or bevacizumab for treatment of wet age-related macular degeneration
por: Rishi, Ekta, et al.
Publicado: (2016)

Transient accumulation of subretinal fluid after half-fluence photodynamic therapy in neovascular age-related macular degeneration
por: Kim, Min Ho, et al.
Publicado: (2021)

Neutrophils homing into the retina trigger pathology in early age-related macular degeneration
por: Ghosh, Sayan, et al.
Publicado: (2019)

Exposure to lower red to far-red light ratios improve tomato tolerance to salt stress
por: Cao, Kai, et al.
Publicado: (2018)

Thrombospondin-1 proteomimetic polymers exhibit anti-angiogenic activity in a neovascular age-related macular degeneration mouse model
por: Choi, Wonmin, et al.
Publicado: (2023)

Effect of Factor XIII-A G185T Polymorphism on Visual Prognosis after Photodynamic Therapy for Neovascular Macular Degeneration
por: Parmeggiani, Francesco, et al.
Publicado: (2015)

Impact of methylenetetrahydrofolate reductase C677T polymorphism on the efficacy of photodynamic therapy in patients with neovascular age-related macular degeneration
por: Parmeggiani, Francesco, et al.
Publicado: (2019)

Intravitreal Aflibercept Versus Photodynamic Therapy in Chinese Patients with Neovascular Age-Related Macular Degeneration: Outcomes of the SIGHT Study
por: Li, Xiaoxin, et al.
Publicado: (2017)

ARMS2 variants may predict the 3-year outcome of photodynamic therapy for wet age-related macular degeneration
por: Nakai, Shunichiro, et al.
Publicado: (2017)

Macrophages and Macular Degeneration
por: Jager, Martine J.
Publicado: (2014)

Brolucizumab for macular degeneration
Publicado: (2020)

Relationships of orientation discrimination threshold and visual acuity with macular lesions in age-related macular degeneration
por: Fu, Haojie, et al.
Publicado: (2017)

Alterations of color vision and pupillary light responses in age-related macular degeneration
por: Decleva, Diego, et al.
Publicado: (2023)

Nutrients for Prevention of Macular Degeneration and Eye-Related Diseases
por: Khoo, Hock Eng, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rqbjbft7lc4nhc0bcr6qcsikko